Cite
Gray RT, Cantwell MM, Coleman HG, et al. Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study. Clin Transl Gastroenterol. 2017;8(4):e91doi: 10.1038/ctg.2017.18.
Gray, R. T., Cantwell, M. M., Coleman, H. G., Loughrey, M. B., Bankhead, P., McQuaid, S., O'Neill, R. F., Arthur, K., Bingham, V., McGready, C., Gavin, A. T., Cardwell, C. R., Johnston, B. T., James, J. A., Hamilton, P. W., Salto-Tellez, M., & Murray, L. J. (2017). Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study. Clinical and translational gastroenterology, 8(4), e91. https://doi.org/10.1038/ctg.2017.18
Gray, Ronan T, et al. "Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study." Clinical and translational gastroenterology vol. 8,4 (2017): e91. doi: https://doi.org/10.1038/ctg.2017.18
Gray RT, Cantwell MM, Coleman HG, Loughrey MB, Bankhead P, McQuaid S, O'Neill RF, Arthur K, Bingham V, McGready C, Gavin AT, Cardwell CR, Johnston BT, James JA, Hamilton PW, Salto-Tellez M, Murray LJ. Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study. Clin Transl Gastroenterol. 2017 Apr 27;8(4):e91. doi: 10.1038/ctg.2017.18. PMID: 28448072; PMCID: PMC5543466.
Copy
Download .nbib